Fonar Total Assets 2006-2019 | FONR
Fonar total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
| Fonar Annual Total Assets (Millions of US $) |
|
|---|---|
| 2018 | $118 |
| 2017 | $99 |
| 2016 | $85 |
| 2015 | $76 |
| 2014 | $77 |
| 2013 | $73 |
| 2012 | $34 |
| 2011 | $32 |
| 2010 | $22 |
| 2009 | $28 |
| 2008 | $35 |
| 2007 | $41 |
| 2006 | $57 |
| 2005 | $76 |
| Fonar Quarterly Total Assets (Millions of US $) |
|
|---|---|
| Q3 2019 | $127 |
| Q2 2018 | $123 |
| Q1 2018 | $120 |
| Q4 2018 | $118 |
| Q3 2018 | $107 |
| Q2 2017 | $105 |
| Q1 2017 | $101 |
| Q4 2017 | $99 |
| Q3 2017 | $92 |
| Q2 2016 | $88 |
| Q1 2016 | $86 |
| Q4 2016 | $85 |
| Q3 2016 | $82 |
| Q2 2015 | $80 |
| Q1 2015 | $79 |
| Q4 2015 | $76 |
| Q3 2015 | $75 |
| Q2 2014 | $79 |
| Q1 2014 | $79 |
| Q4 2014 | $77 |
| Q3 2014 | $76 |
| Q2 2013 | $77 |
| Q1 2013 | $76 |
| Q4 2013 | $73 |
| Q3 2013 | $73 |
| Q2 2012 | $37 |
| Q1 2012 | $35 |
| Q4 2012 | $34 |
| Q3 2012 | $35 |
| Q2 2011 | $33 |
| Q1 2011 | $33 |
| Q4 2011 | $32 |
| Q3 2011 | $26 |
| Q2 2010 | $24 |
| Q1 2010 | $22 |
| Q4 2010 | $22 |
| Q3 2010 | $23 |
| Q2 2009 | $25 |
| Q1 2009 | $27 |
| Q4 2009 | $28 |
| Q3 2009 | $30 |
| Q2 2008 | $33 |
| Q1 2008 | $33 |
| Q4 2008 | $35 |
| Q3 2008 | $41 |
| Q2 2007 | $41 |
| Q1 2007 | $42 |
| Q4 2007 | $41 |
| Q3 2007 | $48 |
| Q2 2006 | $53 |
| Q1 2006 | $54 |
| Q4 2006 | $57 |
| Q3 2006 | $62 |
| Q2 2005 | $69 |
| Q1 2005 | $70 |
| Q4 2005 | $76 |
| Q3 2005 | $75 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.141B | $0.082B |
| FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $151.296B | 28.49 |
| Medtronic (MDT) | Ireland | $135.350B | 19.33 |
| Stryker (SYK) | United States | $77.587B | 27.69 |
| Boston Scientific (BSX) | United States | $58.741B | 28.16 |
| Baxter (BAX) | United States | $42.165B | 26.58 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $28.527B | 0.00 |
| Coloplast (CLPBY) | Denmark | $25.661B | 40.97 |
| Lonza Group Ag (LZAGY) | Switzerland | $25.304B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $25.194B | 16.19 |
| Terumo (TRUMY) | Japan | $22.193B | 25.52 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $19.113B | 0.00 |
| ResMed (RMD) | United States | $17.749B | 33.91 |
| Canopy Growth (CGC) | Canada | $12.652B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $12.175B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.194B | 48.74 |
| Aurora Cannabis (ACB) | Canada | $7.514B | 74.10 |
| William Demant Holdings (WILYY) | Denmark | $7.411B | 0.00 |
| Insulet (PODD) | United States | $7.236B | 527.17 |
| Hill-Rom Holdings (HRC) | United States | $7.121B | 21.59 |
| Perrigo (PRGO) | Ireland | $6.850B | 11.58 |
| GN STORE NORD (GNNDY) | Denmark | $6.409B | 32.73 |
| Haemonetics (HAE) | United States | $6.254B | 51.05 |
| ICU Medical (ICUI) | United States | $5.122B | 30.57 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.916B | 0.00 |
| Neogen (NEOG) | United States | $3.373B | 54.85 |
| NuVasive (NUVA) | United States | $2.987B | 24.39 |
| Hutchison China MediTech (HCM) | China | $2.906B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $2.848B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.479B | 52.82 |
| Quidel (QDEL) | United States | $2.261B | 23.46 |
| Aphria (APHA) | $1.646B | 0.00 | |
| Cardiovascular Systems (CSII) | United States | $1.530B | 878.80 |
| Phibro Animal Health (PAHC) | United States | $1.212B | 18.16 |
| AtriCure (ATRC) | United States | $1.196B | 0.00 |
| VAREX IMAGING (VREX) | United States | $1.177B | 24.98 |
| NanoString Technologies (NSTG) | United States | $1.065B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $1.052B | 27.95 |
| PetIQ (PETQ) | United States | $1.008B | 24.49 |
| Quanterix (QTRX) | United States | $0.783B | 0.00 |
| Cerus (CERS) | United States | $0.769B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.758B | 21.26 |
| Omeros (OMER) | United States | $0.758B | 0.00 |
| MacroGenics (MGNX) | United States | $0.740B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.686B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.591B | 28.62 |
| Surmodics (SRDX) | United States | $0.533B | 77.45 |
| OraSure Technologies (OSUR) | United States | $0.522B | 24.06 |
| Meridian Bioscience (VIVO) | United States | $0.489B | 14.96 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.398B | 0.00 |
| Vapotherm (VAPO) | United States | $0.337B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.325B | 22.51 |
| BioLife Solutions (BLFS) | United States | $0.313B | 97.88 |
| Zynex (ZYXI) | United States | $0.242B | 24.90 |
| Cytosorbents (CTSO) | United States | $0.234B | 0.00 |
| Bovie Medical (APYX) | United States | $0.224B | 0.00 |
| Chimerix (CMRX) | United States | $0.184B | 0.00 |
| Owens & Minor (OMI) | United States | $0.178B | 3.77 |
| United Health Products (UEEC) | United States | $0.175B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.168B | 0.00 |
| Female Health (VERU) | United States | $0.143B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.100B | 0.00 |
| United-Guardian (UG) | United States | $0.091B | 19.97 |
| InfuSystems Holdings (INFU) | United States | $0.088B | 0.00 |
| Surface Oncology (SURF) | United States | $0.076B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.066B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.057B | 19.58 |
| MRI INTERVENTNS (MRIC) | United States | $0.053B | 0.00 |
